Article
Bleomycin Suppresses the Proliferation and the Mobility of Human Gastric Cancer Cells Through the Smad Signaling Pathway.
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology - 1 Jan 2016
Liu Jin-Fang, Nie Xiao-Cui, Shao You-Cheng, Su Wen-Hui, Ma Hai-Ying, Xu Xiao-Yan
Abstract excerpt
BACKGROUND/AIMS: Extensive studies have demonstrated that Bleomycin (BLM) is a glycopeptide antibiotic that has been used as an anticancer chemotherapeutic reagent. It can induce both single- and double-strand DNA damage, inhibit synthesis of DNA, suppress proliferation, and induce apoptosis in cancer cells. Smad signaling transducers are considered as important molecules in tumor development and progression, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
